A recent retrospective study in Clinics and Practice highlights a key challenge in carotid artery stenting (CAS): many patients on standard dual antiplatelet therapy exhibit high on-treatment platelet reactivity (HTPR) — meaning the medication isn’t adequately inhibiting platelet activity, a risk factor for post-procedural thrombotic events. What’s especially insightful is the role of Multiplate® platelet function analysis in identifying this issue. The study found: ✔️ ~31% o